Medication and dosage considerations in the prophylaxis and treatment of high-altitude illness

Chest

Volumn 133, Issue 3, 2008, Pages 744-755

  Luks, Andrew M ^a   Swenson, Erik R ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Puget Sound Veterans Administration Health Care System   (United States)

Author keywords

Acetazolamide; Acute mountain sickness; Altitude; Dexamethasone; High altitude cerebral edema; High altitude pulmonary edema; Nifedipine; Sildenafil; Tadalafil

Indexed keywords

ACETAZOLAMIDE; ACETYLSALICYLIC ACID; AMPHETAMINE; ANTIBIOTIC AGENT; ANTIEMETIC AGENT; ANTIMALARIAL AGENT; AZITHROMYCIN; BARBITURIC ACID DERIVATIVE; CARBAMAZEPINE; CHLOROQUINE; CLARITHROMYCIN; CORTICOSTEROID; CYCLOSPORIN; DEXAMETHASONE; DIGOXIN; DIURETIC AGENT; DORZOLAMIDE; DROPERIDOL; EPHEDRINE; FUROSEMIDE; HYDROCHLOROTHIAZIDE; MACROLIDE; NIFEDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SALMETEROL; SILDENAFIL; TADALAFIL; TOPIRAMATE; UNINDEXED DRUG;

ALTITUDE DISEASE; BACKACHE; DRUG ELIMINATION; DRUG SAFETY; HUMAN; KIDNEY FAILURE; LIVER FAILURE; MYALGIA; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; PROPHYLAXIS; RECOMMENDED DRUG DOSE; REVIEW; TRAVELLER DIARRHEA;

EID: 40549107156     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.07-1417     Document Type: Article

References (104)

1. Grissom CK Roach RC Sarnquist FH Acetazolamide in the treatment of acute mountain sickness: clinical efficacy and effect on gas exchange Ann Intern Med 116 1992 461 465
2. Basnyat B Gertsch JH Holck PS Acetazolamide 125 mg BD is not significantly different from 375 mg BD in the prevention of acute mountain sickness: the Prophylactic Acetazolamide Dosage Comparison for Efficacy (PACE) trial High Alt Med Biol 7 2006 17 27
3. Oelz O Maggiorini M Ritter M Nifedipine for high altitude pulmonary oedema Lancet 2 1989 1241 1244
4. Maggiorini M Brunner-La Rocca HP Peth S Both tadalafil and dexamethasone may reduce the incidence of high-altitude pulmonary edema: a randomized trial Ann Intern Med 145 2006 497 506
5. Sartori C Allemann Y Duplain H Salmeterol for the prevention of high-altitude pulmonary edema N Engl J Med 346 2002 1631 1636
6. Hackett PH Roach RC High-altitude illness N Engl J Med 345 2001 107 114
7. Basnyat B Murdoch DR High-altitude illness Lancet 361 2003 1967 1974
8. Hackett P High altitude and common medical conditions Hornbein TF Schoene RB High altitude: an exploration of human adaptation 2001 Marcel Dekker New York, NY 839 885
9. Luks AM Swenson ER Travel to high altitude with pre-existing lung disease Eur Respir J 29 2007 770 792
10. Bartsch P Gibbs JS The effect of altitude on the heart and lungs Circulation 116 2007 2191 2202
11. Jean D Leal C Kriemler S Medical recommendations for women going to altitude High Alt Med Biol 6 2005 22 31
12. Baumgartner RW Siegel AM Hackett PH Going high with preexisting neurological conditions High Alt Med Biol 8 2007 108 116
13. Brubaker PL Adventure travel and type 1 diabetes: the complicating effects of high altitude Diabetes Care 28 2005 2563 2572
14. Leal C Going high with type 1 diabetes High Alt Med Biol 6 2005 14 21
15. Mader TH Tabin G Going to high altitude with preexisting ocular conditions High Alt Med Biol 4 2003 419 430
16. Hackett PH Rennie D The incidence, importance, and prophylaxis of acute mountain sickness Lancet 2 1976 1149 1155
17. Bartsch P Mairbaurl H Swenson ER High altitude pulmonary oedema Swiss Med Wkly 133 2003 377 384
18. Bartsch P Mairbaurl H Maggiorini M Physiological aspects of high-altitude pulmonary edema J Appl Physiol 98 2005 1101 1110
19. Breastfeeding and maternal medication 2002 World Health Organization Geneva, Switzerland
20. Product information: Decadron®, dexamethasone 1997 Merck & Company West Point, PA
21. Hohne C Krebs MO Seiferheld M Acetazolamide prevents hypoxic pulmonary vasoconstriction in conscious dogs J Appl Physiol 97 2004 515 521
22. Hohne C Pickerodt PA Francis RC Pulmonary vasodilation by acetazolamide during hypoxia is unrelated to carbonic anhydrase inhibition Am J Physiol Lung Cell Mol Physiol 292 2007 L178 L184
23. Teppema LJ Balanos GM Steinback CD Effects of acetazolamide on ventilatory, cerebrovascular, and pulmonary vascular responses to hypoxia Am J Respir Crit Care Med 175 2007 277 281
24. Anderson RJ Gambertoglio JG Schrier RW Clinical use of drugs in renal failure 1976 Charles C. Thomas Springfield, IL
25. Gomolin IH Chapron DJ Elucidating the relationship between acetazolamide plasma protein binding and renal clearance using an albumin infusion J Clin Pharmacol 32 1992 1028 1032
26. Bennett WM Drug prescribing in renal failure: dosing guidelines for adults 1st ed. 1987 American College of Physicians Philadelphia, PA
27. Paisley KE Tomson CR Calcium phosphate stones during long-term acetazolamide treatment for epilepsy Postgrad Med J 75 1999 427 428
28. Pepys MB Acetazolamide and renal stone formation Lancet 1 1970 837
29. Friedland BR Maren TH Carbonic anhydrase: pharmacology of inhibitors and treatment of glaucoma Sears ML Handbook of experimental pharmacology 1984 Springer-Verlag Berlin 279 309
30. Dawson AM De Groote J Rosenthal WA The effects of diamox ammonia metabolism in liver disease Clin Sci (Lond) 16 1957 413 420
31. Haussinger D Gerok W Hepatic urea synthesis and pH regulation: role of CO2, HCO3-, pH and the activity of carbonic anhydrase Eur J Biochem 152 1985 381 386
32. Swenson ER Carbonic anhydrase inhibitors and ventilation: a complex interplay of stimulation and suppression Eur Respir J 12 1998 1242 1247
33. Coudon WL Block AJ Acute respiratory failure precipitated by a carbonic anhydrase inhibitor Chest 69 1976 112 113
34. Lee AG Anderson R Kardon RH Presumed “sulfa allergy” in patients with intracranial hypertension treated with acetazolamide or furosemide: cross-reactivity, myth or reality? Am J Ophthalmol 138 2004 114 118
35. Strom BL Schinnar R Apter AJ Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics N Engl J Med 349 2003 1628 1635
36. Gerhards LJ van Arnhem AC Holman ND Fatal anaphylactic reaction after oral acetazolamide (Diamox) for glaucoma [in Dutch] Ned Tijdschr Geneeskd 144 2000 1228 1230
37. Tzanakis N Metzidaki G Thermos K Anaphylactic shock after a single oral intake of acetazolamide [letter] Br J Ophthalmol 82 1998 588
38. Scott WJ Duggan CA Schreiner CM Reduction of embryonic intracellular pH: a potential mechanism of acetazolamide-induced limb malformations Toxicol Appl Pharmacol 103 1990 238 254
39. Notarianni LJ Plasma protein binding of drugs in pregnancy and in neonates Clin Pharmacokinet 18 1990 20 36
40. Sweeney KR Chapron DJ Brandt JL Toxic interaction between acetazolamide and salicylate: case reports and a pharmacokinetic explanation Clin Pharmacol Ther 40 1986 518 524
41. Hill JB Experimental salicylate poisoning: observations on the effects of altering blood pH on tissue and plasma salicylate concentrations Pediatrics 47 1971 658 665
42. Dorzolamide (Trusopt®) package insert 2004 Merck & Co Whitehouse Station, NJ
43. Topamax® (topiramate) package insert 2005 Ortho-McNeil Pharmaceutical Raritan, NJ
44. Spina E Pisani F Perucca E Clinically significant pharmacokinetic drug interactions with carbamazepine: an update Clin Pharmacokinet 31 1996 198 214
45. Lanoxin® (digoxin) package insert 2001 Glaxo Smith Kline Research Triangle Park, NC
46. Product information: Inapsine®, droperidol 2001 Akorn Decatur, IL
47. Hoffman BB Lefkowitz RJ Catecholamines and sympathomimetic drugs Gilman AG Rall TW Nies AS Goodman and Gilman’s pharmacologic basis of therapeutics 1990 Pergamon Press New York, NY 211 212
48. Tabbara KF Al-Faisal Z Al-Rashed W Interaction between acetazolamine and cyclosporine Arch Ophthalmol 116 1998 832 833
49. Stuiver PC Goud TJ Corticosteroids and liver amoebiasis BMJ 2 1978 394 395
50. Keiser PB Nutman TB Strongyloides stercoralis in the immunocompromised population Clin Microbiol Rev 17 2004 208 217
51. Nielsen GL Sorensen HT Mellemkjoer L Risk of hospitalization resulting from upper gastrointestinal bleeding among patients taking corticosteroids: a register-based cohort study Am J Med 111 2001 541 545
52. Messer J Reitman D Sacks HS Association of adrenocorticosteroid therapy and peptic-ulcer disease N Engl J Med 309 1983 21 24
53. Wu T Liu J Alcohol and aspirin in combination with dexamethasone causes gastrointestinal bleeding at high altitude Wilderness Environ Med 17 2006 69 71
54. Wu TY Ding SQ Liu JL High-altitude gastrointestinal bleeding: an observation in Qinghai-Tibetan railroad construction workers on Mountain Tanggula World J Gastroenterol 13 2007 774 780
55. Olivesi A Modified elimination of prednisolone in epileptic patients on carbamazepine monotherapy, and in women using low-dose oral contraceptives Biomed Pharmacother 40 1986 301 308
56. Gambertoglio JG Holford NH Kapusnik JE Disposition of total and unbound prednisolone in renal transplant patients receiving anticonvulsants Kidney Int 25 1984 119 123
57. McLelland J Jack W Phenytoin/dexamethasone interaction: a clinical problem Lancet 1 1978 1096 1097
58. Levofloxacin (Levaquin): full U.S. prescribing information 2000 Ortho-McNeil Raritan, NJ
59. van Bortel L Bohm R Mooij J Total and free steady-state plasma levels and pharmacokinetics of nifedipine in patients with terminal renal failure Eur J Clin Pharmacol 37 1989 185 189
60. Bogaert MG Rosseel MT Joos R Plasma concentrations of nifedipine in patients with renal failure Arzneimittelforschung 34 1984 307 308
61. Swan SK Bennett WM Drug dosing guidelines in patients with renal failure West J Med 156 1992 633 638
62. Ene MD Roberts CJ Pharmacokinetics of nifedipine after oral administration in chronic liver disease J Clin Pharmacol 27 1987 1001 1004
63. Kleinbloesem CH van Harten J Wilson JP Nifedipine: kinetics and hemodynamic effects in patients with liver cirrhosis after intravenous and oral administration Clin Pharmacol Ther 40 1986 21 28
64. Horton R Spinning the risks and benefits of calcium antagonists Lancet 346 1995 586 587
65. Psaty BM Heckbert SR Koepsell TD The risk of myocardial infarction associated with antihypertensive drug therapies JAMA 74 1995 620 625
66. Furberg CD Psaty BM Meyer JV Nifedipine: dose-related increase in mortality in patients with coronary heart disease Circulation 92 1995 1326 1331
67. Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding. Ad Hoc Subcommittee of the Liaison Committee of the World Health Organisation and the International Society of Hypertension J Hypertens 15 1997 105 115
68. Lubsen J Wagener G Kirwan BA Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with symptomatic stable angina and hypertension: the ACTION trial J Hypertens 23 2005 641 648
69. Yui Y Sumiyoshi T Kodama K Comparison of nifedipine retard with angiotensin converting enzyme inhibitors in Japanese hypertensive patients with coronary artery disease: the Japan Multicenter Investigation for Cardiovascular Diseases-B (JMIC-B) randomized trial Hypertens Res 27 2004 181 191
70. Bailey DG Dresser GK Interactions between grapefruit juice and cardiovascular drugs Am J Cardiovasc Drugs 4 2004 281 297
71. Kaplan RC Heckbert SR Koepsell TD Use of calcium-channel blockers and risk of hospitalized gastrointestinal tract bleeding Arch Intern Med 160 2000 1849 1855
72. Lanas A Serrano P Bajador E Risk of upper gastrointestinal bleeding associated with non-aspirin cardiovascular drugs, analgesics and nonsteroidal anti-inflammatory drugs Eur J Gostroenterol Hepatol 15 2003 173 178
73. Smalley WE Ray WA Daugherty JR No association between calcium channel blocker and confirmed bleeding peptic ulcer disease Am J Epidemiol 148 1998 350 354
74. Bortolotti M Labriola E Bacchelli S “Oesophageal angina” in patients with angina pectoris: a possible side effect of chronic therapy with nitroderivates and Ca-antagonists Ital J Gastroenterol 24 1992 405 408
75. Petersen KU Jaspersen D Medication-induced oesophageal disorders Expert Opin Drug Saf 2 2003 495 507
76. Chow T Browne V Heileson HL Ginkgo biloba and acetazolamide prophylaxis for acute mountain sickness: a randomized, placebo-controlled trial Arch Intern Med 165 2005 296 301
77. Gertsch JH Basnyat B Johnson EW Randomised, double blind, placebo controlled comparison of ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the prevention of high altitude illness trial (PHAIT) BMJ 328 2004 797
78. Gertsch JH Seto TB Mor J Ginkgo biloba for the prevention of severe acute mountain sickness (AMS) starting one day before rapid ascent High Alt Med Biol 3 2002 29 37
79. Roncin JP Schwartz F D’Arbigny P EGb 761 in control of acute mountain sickness and vascular reactivity to cold exposure Aviat Space Environ Med 67 1996 445 452
80. Smith M Lin KM Zheng YP An open-trial of nifedipine-herb interactions: nifedipine with St. John’s wort, ginseng, or gingko biloba [abstract] Clin Pharmacol Ther 69 2001 86
81. Yoshioka M Ohnishi N Koishi T Studies on interactions between functional foods or dietary supplements and medicines: IV. Effects of ginkgo biloba leaf extract on the pharmacokinetics and pharmacodynamics of nifedipine in healthy volunteers Biol Pharm Bull 27 2004 2006 2009
82. Fagenholz PJ Gutman JA Murray AF Treatment of high altitude pulmonary edema at 4240 m in Nepal High Alt Med Biol 8 2007 139 146
83. Das BB Wolfe RR Chan KC High-altitude pulmonary edema in children with underlying cardiopulmonary disorders and pulmonary hypertension living at altitude Arch Pediatr Adolesc Med 158 2004 1170 1176
84. Forgue ST Phillips DL Bedding AW Effects of gender, age, diabetes mellitus and renal and hepatic impairment on tadalafil pharmacokinetics Br J Clin Pharmacol 63 2007 24 35
85. Muirhead GJ Wilner K Colburn W The effects of age and renal and hepatic impairment on the pharmacokinetics of sildenafil Br J Clin Pharmacol 53 suppl 1 2002 21S 30S
86. Grossman EB Swan SK Muirhead GJ The pharmacokinetics and hemodynamics of sildenafil citrate in male hemodialysis patients Kidney Int 66 2004 367 374
87. Product information Revatio (sildenafil citrate) oral tabs 2006 Pfizer New York, NY
88. Tadalafil {Cialis} US prescribing information. Lilly ICOS LLC. Indianapolis, IN:
89. Product information: Viagra, sildenafil citrate 2000 Pfizer New York, NY
90. Callejas Rubio JL Salmeron Escobar J Gonzalez-Calvin J Successful treatment of severe portopulmonary hypertension in a patient with Child C cirrhosis by sildenafil Liver Transpl 12 2006 690 691
91. Makisalo H Koivusalo A Vakkuri A Sildenafil for portopulmonary hypertension in a patient undergoing liver transplantation Liver Transpl 10 2004 945 950
92. Wang YW Lin HC Yang YY Sildenafil decreased pulmonary arterial pressure but may have exacerbated portal hypertension in a patient with cirrhosis and portopulmonary hypertension J Gastroenterol 41 2006 593 597
93. Finley DS Lugo B Ridgway J Fatal variceal rupture after sildenafil use: report of a case Curr Surg 62 2005 55 56
94. Patterson D Kloner R Effron M The effect of tadalafil on the time to exercise-induced myocardial ischaemia in subjects with coronary artery disease Br J Clin Pharmacol 60 2005 459 468
95. Kloner RA Jackson G Hutter AM Cardiovascular safety update of Tadalafil: retrospective analysis of data from placebo-controlled and open-label clinical trials of Tadalafil with as needed, three times-per-week or once-a-day dosing Am J Cardiol 97 2006 1778 1784
96. Arruda-Olson AM Mahoney DW Nehra A Cardiovascular effects of sildenafil during exercise in men with known or probable coronary artery disease: a randomized crossover trial JAMA 287 2002 719 725
97. Fox KM Thadani U Ma PT Sildenafil citrate does not reduce exercise tolerance in men with erectile dysfunction and chronic stable angina Eur Heart J 24 2003 2206 2212
98. Cazzola M Testi R Matera MG Clinical pharmacokinetics of salmeterol Clin Pharmacokinet 41 2002 19 30
99. Manchee GR Eddershaw PJ Ranshaw LE The aliphatic oxidation of salmeterol to alpha-hydroxysalmeterol in human liver microsomes is catalyzed by CYP3A Drug Metab Dispos 24 1996 555 559
100. Ferguson GT Funck-Brentano C Fischer T Cardiovascular safety of salmeterol in COPD Chest 123 2003 1817 1824
101. Tranfa CM Pelaia G Grembiale RD Short-term cardiovascular effects of salmeterol Chest 113 1998 1272 1276
102. Ullman A Svedmyr N Salmeterol, a new long acting inhaled β2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients Thorax 43 1988 674 678
103. Product information: Serevent Diskus inhalation powder, salmeterol xinafoate inhalation powder 2006 Glaxo Smith Kline Research Triangle Park, NC
104. Demaziere J Fourcade JM Busseuil CT The hazards of chloroquine self prescription in West Africa J Toxicol Clin Toxicol 33 1995 369 370